Loading clinical trials...
Loading clinical trials...
"PROSPER-FM": Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management
Conditions
Interventions
Digital ACT
Digital Symptom Tracker
Locations
25
United States
Site #37
Covina, California, United States
Site #15
Oceanside, California, United States
Site #31
San Bernardino, California, United States
Site #38
Thousand Oaks, California, United States
Site #36
Tujunga, California, United States
Site #35
Whittier, California, United States
Start Date
February 8, 2022
Primary Completion Date
May 15, 2023
Completion Date
May 15, 2023
Last Updated
June 15, 2023
NCT05901259
NCT03759522
NCT07186751
NCT06574165
NCT06157866
NCT05067998
Lead Sponsor
Swing Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions